Cocrystal Pharma (COCP) Other Non Operating Income (2012 - 2026)
Cocrystal Pharma (COCP) reported Other Non Operating Income of $35000.0 for Q1 2026, up 1066.67% on a YoY basis from $3000.0 in Q1 2025, and up 337.5% sequentially from $8000.0 in Q4 2025.
Cocrystal Pharma (COCP) Other Non Operating Income (2012 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 14 years of Other Non Operating Income data on file, last reported at $35000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 1066.67% year-over-year to $35000.0; the trailing twelve-month figure through Mar 2026 stood at $86000.0 (up 160.56% YoY), and the FY2025 full-year result was $54000.0, up 133.13% from the prior year.
- Other Non Operating Income climbed to $35000.0 in Q1 2026, from $8000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $35000.0 in Q1 2026 to a low of -$91000.0 in Q4 2024.
- A 5-year average of -$9875.0 and a median of -$3000.0 in 2022 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income slumped 1400.0% in 2022 and soared 3400.0% in 2023, its largest moves.
- Tracing COCP's Other Non Operating Income over 5 years: stood at -$5000.0 in 2022, then soared by 540.0% to $22000.0 in 2023, then sank by 513.64% to -$91000.0 in 2024, then soared by 108.79% to $8000.0 in 2025, then jumped by 337.5% to $35000.0 in 2026.
- Business Quant data shows COCP's Other Non Operating Income at $35000.0 in Q1 2026, $8000.0 in Q4 2025, and $18000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | -91,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -46,000.00 |
| Mar 31, 2024 | -18,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | -42,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | -78,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 9,000.00 |
| Mar 31, 2021 | 1,000.00 |